Utilizing Genomics to Identify Novel Immunotherapeutic Targets in Multiple Myeloma High-Risk Subgroups https://www.biorxiv.org/content/10.1101/2025.01.29.635544v1
03.02.2025 03:37 β π 3 π 2 π¬ 0 π 1
Myeloma / Plasma Cell Dyscrasia ~ #ASH24Top10 (or so) #mmsm #mmMRD #ASH24 - @mtmdphd *DRAFT* Table Update: Nov 18, 2024 - cc @grpetersen1 - @HadidiSamer @RahulBanerjeeMD @szusmani et al.
18.11.2024 19:17 β π 10 π 3 π¬ 0 π 2
Thirsty boy!
15.11.2024 15:35 β π 4 π 0 π¬ 0 π 0
Myeloma & Amyloidosis Specialist
Karmanos Cancer Institute
Detroit, Michigan
Head of Campaigns at Myeloma UK. Mum, volunteer, new to running, always busy.
Kraft family chair and Myeloma doctor @danafarber, Professor @harvardmed, Immediate past President @Myeloma_Society
Washington U. School of Medicine.
Assoc Director Hem/Onc Fellowship.
Myeloma, Amyloidosis, Leukemia, Lymphoma & BMT physician and researcher.
As quoted in the Manchester Evening News. I hope the fame doesnβt destroy me.
haematology registrar PMCC & RMH | research affiliate, PORTAL, BWH/HMS | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer
Sharing, educating and inspiring for all things haematological.
#MedEd
Following every haematology type of person we can find.
Account currently managed by @christiplady.bsky.social
Cell biologist interested in chromosome instability | EMBO postdoc @ University of Oxford
Not a doctor or scientist;
Spouse dx'ed with MM in 2020;
Hope > hype.
Hematologist interested in plasma cell disorders and precursor conditions! π¨π¦π²π½ @Arthur Child Comprehensive Cancer Center, Calgary, AB, Canada
Myeloma clinician and researcher, health tech enthusiast
HΓ¦matolog pΓ₯ Rigshospitalet. // Myeloma doc
https://orcid.org/0000-0002-1754-5336
Molecular biologist. π§¬Principal investigator at University of Amsterdam π³π± Research interests: immune repertoire diversification mechanisms, oncogenic signaling, B-cells, multiple myeloma #medsky #scisky #academicsky #biosky
Post-doc in Myeloma research @AUMC. Interested in signal transduction, metabolomics, stromal interactions and other haematological malignancies.
MD, PhD, Internal Medicine, Senior Exec The Advisory Board, OAS, Oliver Wyman, Ascension, etc. Cancer survivor, Enjoy dinosaurs, thoroughbred race horses, chickens and dogs
NO Crypto NO MAGA NO MAHA NO TRUMP No DM
Malignant Hematology and Solid Tumor Genetics, Mayo Clinic. Physician/Cytogeneticist. Opinions my own/ #MedSky #HemeSky
ARC is accelerating the development of and access to new and innovative treatments for systemic #amyloidosis
Views my own. VP Clinical Partnerships @TempusAI
#PrecisionMedicine #mmsm #lymsm #CCC19 @COVID19nCCC @ASCO COI: https://coi.asco.org/share/RBB-TT6R/Michael
Epigenetic Inheritance, Neuroscience & anything biology-related
https://www.odedrechavilab.com/
TED: https://shorturl.at/myFTY
Huberman Lab Podcast: https://youtu.be/CDUetQMKM6g